Reckitt Benckiser Group plc (RBGPF) Income Statement Analysis

See more : Bachem Holding AG (0QND.L) Income Statement Analysis – Financial Results

Complete financial analysis of Reckitt Benckiser Group plc (RBGPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reckitt Benckiser Group plc, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.

You may be interested

Reckitt Benckiser Group plc (RBGPF)

Industry: Household & Personal Products

Sector: Consumer Defensive

Website: https://www.reckitt.com

About Reckitt Benckiser Group plc

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	14.61B	14.45B	13.23B	13.99B	12.85B	12.60B	11.51B	9.89B	8.87B	8.84B	10.04B	9.57B	9.49B	8.45B	7.75B	6.56B	5.27B	4.92B	4.18B	3.87B	3.71B	3.45B
Cost of Revenue	5.85B	6.09B	5.56B	5.56B	5.07B	4.96B	4.64B	3.87B	3.63B	3.74B	4.07B	4.03B	3.82B	3.33B	3.09B	2.67B	2.20B	2.13B	1.89B	1.75B	1.74B	1.68B
Gross Profit	8.76B	8.36B	7.68B	8.44B	7.78B	7.64B	6.87B	6.03B	5.25B	5.10B	5.97B	5.54B	5.66B	5.12B	4.66B	3.89B	3.07B	2.79B	2.29B	2.12B	1.98B	1.78B
Gross Profit Ratio	59.97%	57.85%	58.00%	60.28%	60.55%	60.61%	59.68%	60.92%	59.12%	57.67%	59.43%	57.88%	59.69%	60.58%	60.16%	59.27%	58.30%	56.66%	54.87%	54.79%	53.27%	51.42%
Research & Development	337.00M	325.00M	313.00M	288.00M	257.00M	223.00M	187.00M	149.00M	140.00M	146.00M	199.00M	171.00M	26.00M	33.00M	119.00M	102.00M	88.00M	82.00M	63.00M	66.00M	57.00M	54.00M
General & Administrative	1.38B	1.21B	1.19B	1.39B	740.00M	890.00M	728.00M	648.00M	575.00M	528.00M	692.00M	491.00M	578.00M	0.00	0.00	0.00	0.00	313.00M	0.00	0.00	0.00	0.00
Selling & Marketing	3.70B	3.44B	3.46B	3.61B	3.42B	3.17B	3.00B	2.46B	2.17B	2.25B	2.47B	2.32B	2.30B	0.00	2.10B	1.84B	1.50B	0.00	0.00	0.00	0.00	0.00
SG&A	5.09B	4.64B	4.65B	5.00B	4.16B	4.06B	3.72B	3.11B	2.74B	2.78B	3.16B	2.81B	2.88B	0.00	2.10B	1.84B	1.50B	313.00M	0.00	0.00	0.00	0.00
Other Expenses	807.00M	158.00M	-1.00M	-2.00M	202.00M	0.00	0.00	59.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	6.23B	5.13B	4.96B	5.29B	4.62B	4.59B	4.13B	3.62B	3.01B	2.93B	3.62B	3.10B	3.28B	3.02B	2.77B	2.38B	1.94B	1.72B	1.45B	1.36B	1.29B	1.19B
Cost & Expenses	12.08B	11.22B	10.52B	10.85B	9.68B	9.55B	8.78B	7.48B	6.63B	6.67B	7.70B	7.13B	7.10B	6.36B	5.86B	5.05B	4.13B	3.86B	3.34B	3.11B	3.03B	2.87B
Interest Income	6.00M	29.00M	29.00M	77.00M	161.00M	78.00M	60.00M	42.00M	21.00M	27.00M	25.00M	26.00M	23.00M	21.00M	17.00M	31.00M	22.00M	17.00M	32.00M	12.00M	24.00M	20.00M
Interest Expense	295.00M	257.00M	244.00M	363.00M	314.00M	403.00M	298.00M	58.00M	54.00M	65.00M	56.00M	41.00M	38.00M	12.00M	16.00M	62.00M	46.00M	53.00M	13.00M	27.00M	43.00M	52.00M
Depreciation & Amortization	470.00M	604.00M	429.00M	470.00M	436.00M	404.00M	268.00M	227.00M	171.00M	161.00M	171.00M	148.00M	157.00M	144.00M	139.00M	107.00M	93.00M	97.00M	91.00M	94.00M	84.00M	82.00M
EBITDA	3.17B	3.90B	465.00M	3.61B	3.78B	3.48B	2.98B	2.64B	2.42B	2.34B	2.05B	2.61B	2.56B	2.26B	2.05B	1.65B	1.35B	1.02B	980.00M	879.00M	792.00M	679.00M
EBITDA Ratio	21.67%	27.23%	29.99%	32.89%	29.89%	27.59%	26.23%	26.64%	27.42%	26.62%	25.30%	27.27%	27.05%	26.77%	26.40%	25.11%	23.76%	23.93%	23.00%	22.37%	21.55%	19.83%
Operating Income	2.53B	3.25B	3.49B	3.15B	-1.71B	3.05B	2.74B	2.41B	2.24B	2.16B	2.35B	2.44B	2.40B	2.13B	1.89B	1.51B	1.23B	910.00M	840.00M	749.00M	679.00M	576.00M
Operating Income Ratio	17.33%	22.48%	26.36%	22.48%	-13.34%	24.19%	23.78%	24.37%	25.25%	24.49%	23.35%	25.45%	25.25%	25.20%	24.39%	22.93%	23.40%	18.49%	20.10%	19.35%	18.29%	16.68%
Total Other Income/Expenses	-130.00M	-182.00M	544.00M	-1.27B	-153.00M	-338.00M	-238.00M	-16.00M	-33.00M	-38.00M	-31.00M	-150.00M	-19.00M	6.00M	1.00M	-31.00M	-24.00M	-36.00M	36.00M	9.00M	-19.00M	-31.00M
Income Before Tax	2.40B	3.07B	-260.00M	1.87B	-2.11B	2.72B	2.50B	2.39B	2.21B	2.13B	2.31B	2.42B	2.38B	2.14B	1.89B	1.47B	1.21B	874.00M	876.00M	758.00M	660.00M	545.00M
Income Before Tax Ratio	16.44%	21.22%	-1.96%	13.39%	-16.40%	21.61%	21.71%	24.20%	24.88%	24.06%	23.04%	25.30%	25.05%	25.27%	24.40%	22.46%	22.95%	17.76%	20.96%	19.58%	17.78%	15.78%
Income Tax Expense	753.00M	711.00M	-208.00M	720.00M	665.00M	536.00M	-894.00M	558.00M	463.00M	462.00M	574.00M	587.00M	622.00M	566.00M	474.00M	354.00M	271.00M	200.00M	207.00M	181.00M	171.00M	137.00M
Net Income	1.64B	2.33B	-52.00M	1.19B	-2.77B	2.16B	6.17B	1.83B	1.74B	3.22B	1.74B	1.82B	1.75B	1.57B	1.42B	1.12B	938.00M	674.00M	669.00M	577.00M	489.00M	408.00M
Net Income Ratio	11.25%	16.12%	-0.39%	8.48%	-21.58%	17.14%	53.61%	18.52%	19.64%	36.48%	17.32%	19.03%	18.40%	18.55%	18.29%	17.07%	17.80%	13.69%	16.01%	14.91%	13.17%	11.81%
EPS	2.27	3.27	-0.07	1.67	-3.91	3.06	8.79	2.60	2.44	4.47	2.42	2.51	2.40	2.17	1.99	1.58	1.31	0.94	0.92	0.81	0.69	0.58
EPS Diluted	2.29	3.26	-0.07	1.66	-3.91	3.05	8.68	2.57	2.41	4.41	2.38	2.48	2.37	2.14	1.95	1.55	1.28	0.92	0.90	0.77	0.66	0.56
Weighted Avg Shares Out	722.52M	715.28M	713.76M	710.91M	708.69M	705.90M	702.38M	704.16M	713.06M	720.82M	718.38M	724.24M	727.63M	724.19M	713.00M	710.57M	715.04M	720.69M	727.06M	714.86M	706.89M	704.35M
Weighted Avg Shares Out (Dil)	718.28M	717.49M	713.76M	713.75M	708.69M	709.00M	711.12M	714.30M	723.55M	730.74M	729.05M	733.00M	735.83M	733.30M	728.17M	724.11M	733.63M	734.20M	743.26M	754.55M	758.10M	756.53M

Reckitt Benckiser: Potential For Strong Free Cash Flow

July 6, 2023seekingalpha.com

Reckitt Benckiser Group is a global manufacturer and seller of health, hygiene, and nutrition products. Reckitt has benefited well from the pandemic, but is fundamentally attractive due to the brands it owns. Margins are above the industry average, allowing Reckitt...

Reckitt Benckiser Group plc (RBGLY) Q1 2023 Earnings Call Transcript

April 29, 2023seekingalpha.com

Reckitt Benckiser Group plc (OTCPK:RBGLY) Q1 2023 Results Conference Call April 26, 2023 1:00 PM ET Company Participants Richard Joyce - IR Nicandro Durante - CEO Jeff Carr - CFO Conference Call Participants Rashad Kawan - Morgan Stanley Guillaume Delmas...

Reckitt Benckiser first quarter revenue rises to $4.9 billion; Kris Licht appointed CEO

April 26, 2023marketwatch.com

Reckitt Benckiser Group PLC UK:RKT said Wednesday that its first-quarter revenue rose, supported by a broad-based growth across its businesses, and said it has appointed Kris Licht as Chief Executive Officer to succeed Nicandro Durante.

Reckitt Benckiser appoints new CEO from within, reports continues price hikes in first quarter

April 26, 2023proactiveinvestors.co.uk

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) revealed it sold lower volumes in the first quarter as it continued to hike prices, and said it is promoting Kris Licht, currently chief customer officer, to be its new chief executive. The maker...

Reckitt Benckiser still faces headwinds, says broker

April 3, 2023proactiveinvestors.co.uk

Reckitt Benckiser still faces headwinds to its ratings, according to Deutsche Bank, which cut its target price to 6,500p from 6,250p while maintaining its hold rating. Analysts at the bank said uncertainty about the level of market share loss in the...

Reckitt Benckiser's first quarter to be ahead of consensus, says broker

March 31, 2023proactiveinvestors.co.uk

Reckitt Benckiser's first-quarter sales are expected to be ahead of Jefferies' previous consensus, with the broker remaining hold on the consumer goods group with a target price of 5,870p. The US bank said that sales, despite its general scepticism, “reflect...

Reckitt Benckiser should enjoy 'more normalised base,' says broker

March 24, 2023proactiveinvestors.co.uk

Reckitt Benckiser should enjoy a more normalised base as it comes out of three years of reinvestment, according to JP Morgan. The US bank has an overweight rating on the stock with a target price set at 7,500p.

Reckitt Benckiser: A Pick To Avoid The Banking Turmoil

March 21, 2023seekingalpha.com

Reckitt Benckiser could report great results for fiscal 2022 with the top and bottom lines improving and all three segments contributing to growth. While management is a little more cautious for 2023 (only low single-digit growth), the long-term targets see...

International Wide-Moat Stocks On Sale - The March 2023 Heat Map

March 8, 2023seekingalpha.com

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.

Reckitt Benckiser 'frustrated' at lack of love but analysts see plenty of question marks

March 6, 2023proactiveinvestors.co.uk

Reckitt Benckiser PLC management's frustration that the market's lack of love is likely to be extended as the shares received another downgrade, with analysts also slamming the ‘mystifying' lack of chief executive appointment six months after the departure of Laxman...

1 2 3 4 5 6

Source: https://incomestatements.info
Category: Stock Reports

Reckitt Benckiser Group plc (RBGPF) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories